{"id":39884,"date":"2023-11-01T12:20:05","date_gmt":"2023-11-01T12:20:05","guid":{"rendered":"https:\/\/prosfunds.com\/markets\/cvs-earnings-top-estimates-but-stock-drops-as-outlook-is-slashed-again\/"},"modified":"2023-11-01T12:20:07","modified_gmt":"2023-11-01T12:20:07","slug":"cvs-earnings-top-estimates-but-stock-drops-as-outlook-is-slashed-again","status":"publish","type":"post","link":"https:\/\/prosfunds.com\/?p=39884","title":{"rendered":"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"WP-BAR-0000787674\">\n<div data-layout=\"wrap\n              \" data-layout-mobile=\"\" class=\"\n        media-object\n        type-InsetMediaIllustration\n          wrap\n  article__inset\n        article__inset--type-InsetMediaIllustration\n          article__inset--wrap\n    article__inset--lead\n  \"><\/p>\n<p>        <!-- eventually when we know what this card will be we can change it and leave this one --><\/p>\n<figure class=\"\n        media-object-image\n        enlarge-image\n        img-wrap\n        article__inset__image\n      \" itemscope=\"\" itemtype=\"http:\/\/schema.org\/ImageObject\"><\/p>\n<\/figure><\/div>\n<p>Investors didn\u2019t seem pleased with a solid earnings and revenue beat from<br \/>\n        CVS Health<span>,<\/span><br \/>\n       with shares in the healthcare company heading lower on Wednesday after the company slashed its full-year guidance for the third consecutive quarter.<\/p>\n<p>\n        CVS<br \/>\n       (ticker: CVS) reported earnings of $2.21 a share on revenue of $89.8 billion, firmly topping expectations among analysts surveyed by FactSet of earnings of $2.13 a share on revenue of $88.3 billion.<\/p>\n<div class=\"paywall\">\n<p>But CVS lowered its guidance range for diluted earnings per share measured under U.S. Generally Accepted Accounting Principles. The company said it now sees earnings by this metric in a range of $6.37 to $6.61 a share. CVS said in February that earnings could be $7.73 to $7.93 a share in 2023 but has revised this range lower in both May and August.<\/p>\n<p>Shares in CVS fell 2.2% in premarket trading on Wednesday.<\/p>\n<p>\u201cDespite a challenging business environment, we continue adapting to the changing needs of our consumers by connecting our care delivery capabilities in communities across the country, broadening access to care and lowering costs,\u201d the company\u2019s CEO, Karen S. Lynch, said in a statement.<\/p>\n<p>Write to Jack Denton at jack.denton@barrons.com<\/p>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/articles\/cvs-stock-earnings-c67bd9d6?mod=markets\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investors didn\u2019t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday after the company slashed its full-year guidance for the third consecutive quarter. CVS (ticker: CVS) reported earnings of $2.21 a share on revenue of $89.8 billion, firmly topping expectations among analysts [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":39885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[33],"tags":[],"class_list":{"0":"post-39884","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-markets"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again | Prosfunds<\/title>\n<meta name=\"description\" content=\"Investors didn\u2019t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prosfunds.com\/?p=39884\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again | Prosfunds\" \/>\n<meta property=\"og:description\" content=\"Investors didn\u2019t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prosfunds.com\/?p=39884\" \/>\n<meta property=\"og:site_name\" content=\"Prosfunds\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-01T12:20:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-01T12:20:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/11\/1698841205_social.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prosfunds.com\/?p=39884#article\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/?p=39884\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\"},\"headline\":\"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again\",\"datePublished\":\"2023-11-01T12:20:05+00:00\",\"dateModified\":\"2023-11-01T12:20:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prosfunds.com\/?p=39884\"},\"wordCount\":204,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"articleSection\":[\"Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/prosfunds.com\/?p=39884#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prosfunds.com\/?p=39884\",\"url\":\"https:\/\/prosfunds.com\/?p=39884\",\"name\":\"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again | Prosfunds\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/#website\"},\"datePublished\":\"2023-11-01T12:20:05+00:00\",\"dateModified\":\"2023-11-01T12:20:07+00:00\",\"description\":\"Investors didn\u2019t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday\",\"breadcrumb\":{\"@id\":\"https:\/\/prosfunds.com\/?p=39884#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prosfunds.com\/?p=39884\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prosfunds.com\/?p=39884#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/prosfunds.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prosfunds.com\/#website\",\"url\":\"https:\/\/prosfunds.com\/\",\"name\":\"Funding Factories\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prosfunds.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prosfunds.com\/#organization\",\"name\":\"Funding Factories\",\"url\":\"https:\/\/prosfunds.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"width\":780,\"height\":140,\"caption\":\"Funding Factories\"},\"image\":{\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/prosfunds.com\"],\"url\":\"https:\/\/prosfunds.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again | Prosfunds","description":"Investors didn\u2019t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prosfunds.com\/?p=39884","og_locale":"en_US","og_type":"article","og_title":"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again | Prosfunds","og_description":"Investors didn\u2019t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday","og_url":"https:\/\/prosfunds.com\/?p=39884","og_site_name":"Prosfunds","article_published_time":"2023-11-01T12:20:05+00:00","article_modified_time":"2023-11-01T12:20:07+00:00","og_image":[{"width":1280,"height":640,"url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/11\/1698841205_social.jpeg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prosfunds.com\/?p=39884#article","isPartOf":{"@id":"https:\/\/prosfunds.com\/?p=39884"},"author":{"name":"News Room","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6"},"headline":"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again","datePublished":"2023-11-01T12:20:05+00:00","dateModified":"2023-11-01T12:20:07+00:00","mainEntityOfPage":{"@id":"https:\/\/prosfunds.com\/?p=39884"},"wordCount":204,"commentCount":0,"publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"articleSection":["Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/prosfunds.com\/?p=39884#respond"]}]},{"@type":"WebPage","@id":"https:\/\/prosfunds.com\/?p=39884","url":"https:\/\/prosfunds.com\/?p=39884","name":"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again | Prosfunds","isPartOf":{"@id":"https:\/\/prosfunds.com\/#website"},"datePublished":"2023-11-01T12:20:05+00:00","dateModified":"2023-11-01T12:20:07+00:00","description":"Investors didn\u2019t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday","breadcrumb":{"@id":"https:\/\/prosfunds.com\/?p=39884#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prosfunds.com\/?p=39884"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prosfunds.com\/?p=39884#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prosfunds.com\/"},{"@type":"ListItem","position":2,"name":"CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed Again"}]},{"@type":"WebSite","@id":"https:\/\/prosfunds.com\/#website","url":"https:\/\/prosfunds.com\/","name":"Funding Factories","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prosfunds.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/prosfunds.com\/#organization","name":"Funding Factories","url":"https:\/\/prosfunds.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","width":780,"height":140,"caption":"Funding Factories"},"image":{"@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","caption":"News Room"},"sameAs":["https:\/\/prosfunds.com"],"url":"https:\/\/prosfunds.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/39884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39884"}],"version-history":[{"count":1,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/39884\/revisions"}],"predecessor-version":[{"id":39886,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/39884\/revisions\/39886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/media\/39885"}],"wp:attachment":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}